180 related articles for article (PubMed ID: 12761502)
1. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
[TBL] [Abstract][Full Text] [Related]
2. A new member of the ETS family fused to EWS in Ewing tumors.
Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
4. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family.
Schneikert J; Lutz Y; Wasylyk B
Oncogene; 1992 Feb; 7(2):249-56. PubMed ID: 1549346
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Ets function by protein - protein interactions.
Li R; Pei H; Watson DK
Oncogene; 2000 Dec; 19(55):6514-23. PubMed ID: 11175367
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of mammalian transcriptional repressors.
Thiel G; Lietz M; Bach K; Guethlein L; Cibelli G
Biol Chem; 2001 Jun; 382(6):891-902. PubMed ID: 11501753
[TBL] [Abstract][Full Text] [Related]
7. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
Wang L; Hiebert SW
Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334
[TBL] [Abstract][Full Text] [Related]
8. TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1.
Wang Y; Li Y; Qi X; Yuan W; Ai J; Zhu C; Cao L; Yang H; Liu F; Wu X; Liu M
Biochem Biophys Res Commun; 2004 Oct; 323(1):9-16. PubMed ID: 15351693
[TBL] [Abstract][Full Text] [Related]
9. Ets-2 interacts with co-repressor BS69 to repress target gene expression.
Wei G; Schaffner AE; Baker KM; Mansky KC; Ostrowski MC
Anticancer Res; 2003; 23(3A):2173-8. PubMed ID: 12894593
[TBL] [Abstract][Full Text] [Related]
10. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
Li R; Pei H; Watson DK; Papas TS
Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of the ets-related human transcription factor ER81.
Monté D; Coutte L; Baert JL; Angeli I; Stéhelin D; de Launoit Y
Oncogene; 1995 Aug; 11(4):771-9. PubMed ID: 7651741
[TBL] [Abstract][Full Text] [Related]
12. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression.
Heinzel T; Lavinsky RM; Mullen TM; Söderstrom M; Laherty CD; Torchia J; Yang WM; Brard G; Ngo SD; Davie JR; Seto E; Eisenman RN; Rose DW; Glass CK; Rosenfeld MG
Nature; 1997 May; 387(6628):43-8. PubMed ID: 9139820
[TBL] [Abstract][Full Text] [Related]
13. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
14. Identification of the transcriptional repression domain of nuclear factor 1-A.
Osada S; Ikeda T; Xu M; Nishihara T; Imagawa M
Biochem Biophys Res Commun; 1997 Sep; 238(3):744-7. PubMed ID: 9325160
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of transcriptional repression by TEL/RUNX1 fusion protein.
Lee YJ; Kim JH; Bae S; Rho SK; Choe SY
Mol Cells; 2004 Apr; 17(2):217-22. PubMed ID: 15179033
[TBL] [Abstract][Full Text] [Related]
16. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation.
Criqui-Filipe P; Ducret C; Maira SM; Wasylyk B
EMBO J; 1999 Jun; 18(12):3392-403. PubMed ID: 10369679
[TBL] [Abstract][Full Text] [Related]
17. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
Kawagoe H; Potter M; Ellis J; Grosveld GC
Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
[TBL] [Abstract][Full Text] [Related]
18. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Petrovas C; Jeay S; Lewis RE; Sonenshein GE
Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
[TBL] [Abstract][Full Text] [Related]
19. A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110.
Cohen SB; Nicol R; Stavnezer E
Oncogene; 1998 Nov; 17(19):2505-13. PubMed ID: 9824161
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
